Oscar Health, Inc.

Oscar Health, Inc. saw a notable increase in its stock price on July 1, 2026, reaching an intraday high. Over the past week and month, the stock has demonstrated strong growth, significantly outperforming the S&P 500. However, the company continues to face challenges with negative operating profits.

Oscar Health, Inc. has achieved a new 52-week high, reflecting a strong year-over-year performance that surpasses broader market trends. Despite challenges such as negative operating profits and a lack of dividends, the company's stock has demonstrated resilience, highlighting its position within the healthcare services industry.

Oscar Health, Inc. has achieved a new 52-week high, reflecting strong performance in the healthcare services industry. Despite historical challenges with operating profits, the company's market capitalization is notable, and its stock has demonstrated significant volatility, highlighting its potential within the market.

Oscar Health, Inc. has achieved a new 52-week high, reflecting a strong performance over the past year with a notable increase from its previous low. Despite challenges such as negative operating profits, the stock's price movement indicates a shift in market dynamics within the healthcare sector.

Oscar Health, Inc. has achieved a new 52-week high, reflecting a significant performance improvement from its previous low. Despite ongoing challenges with negative operating profits, the company's stock has shown a strong recovery, outpacing the S&P 500, and its market capitalization stands at USD 3,320 million.

Oscar Health, Inc. has achieved a new 52-week high, reflecting a strong performance over the past year with a notable increase from its previous low. Despite challenges such as negative operating profits, the company's market capitalization stands at USD 3,320 million, attracting interest in its valuation.

Oscar Health, Inc. has achieved a new 52-week high, reflecting strong performance in the healthcare services sector. The company has demonstrated resilience despite past challenges, with a notable one-year performance exceeding the S&P 500. Its market capitalization is USD 3,320 million, highlighting its small-cap status.

Oscar Health, Inc. has achieved a new 52-week high, reflecting a strong performance over the past year with a notable increase from its previous low. The company, with a market capitalization of USD 3,320 million, has seen a significant rise in profits despite facing operational challenges.

Oscar Health, Inc. has seen a notable decline in its stock today, contrasting with a slight increase in the S&P 500. While the company has experienced significant growth over the past month and year, it faces challenges in the five-year timeframe and reports negative operating profits and margins.

Oscar Health, Inc. has seen a notable increase in its stock price, reflecting strong activity in the healthcare services sector. Despite recent gains, the company faces challenges with negative operating profits and margins, alongside a significant market capitalization and a complex financial landscape characterized by a negative return on equity.

Oscar Health, Inc. experienced a significant one-day performance, outperforming the S&P 500. However, the company reported substantial financial losses, including a low operating profit and negative margins. Mixed technical indicators further complicate its financial outlook as it faces ongoing challenges in the healthcare services sector.

Oscar Health, Inc. has recently revised its evaluation amid changing market conditions. The company's stock price is currently $15.63, reflecting a slight increase. Over the past year, Oscar Health has achieved a 26.56% return, contrasting with the S&P 500's 33.47%. Its performance shows significant volatility over different time frames.

Oscar Health, Inc. has seen a notable rise in its stock performance, achieving a significant weekly increase. Despite facing challenges such as negative operating profits and a history of losses, the company's recent activity reflects resilience in a difficult market environment, attracting investor attention.

Oscar Health, Inc. has experienced a significant stock performance increase, outperforming the S&P 500. Despite this, the company continues to face challenges with negative operating profits for nine quarters and a high debt-to-equity ratio. Its market capitalization is around USD 3,958 million, with notable profit growth over the past year.

Oscar Health, Inc. has reached a new 52-week low, reflecting a challenging year with a notable decline in performance. The company, with a market capitalization of approximately USD 3,958 million, reported significant losses and negative financial metrics, indicating ongoing difficulties in the healthcare sector.

Oscar Health, Inc. has seen a notable rise in its stock today, contrasting with a slight decline in the S&P 500. While the company has experienced significant short-term gains, it faces longer-term challenges, including negative operating profits and a low return on equity, amidst a volatile market environment.

Oscar Health, Inc. saw a significant stock increase today, contrasting with the modest rise of the S&P 500. While the company has gained year-to-date, its longer-term performance shows challenges, including a decline over the past month and a negative one-year return. Oscar Health operates in the healthcare services sector.

Oscar Health, Inc. has seen a significant rise in its stock today, reaching an intraday high and contrasting with a decline in the S&P 500. Year-to-date, the company has outperformed the index, though it has faced challenges over the past year. Its market capitalization stands at USD 5,250 million.

Oscar Health, Inc. achieved a new 52-week high of USD 23.74 on October 7, 2025, reflecting a year-over-year performance of 9.56%. With a market capitalization of USD 5,250 million, the company has a P/E ratio of 32.00 and a price-to-book ratio of 4.53, indicating its valuation dynamics.